Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with her2-positive breast cancer in spain
HIGHLIGHTS who: G. Lopez-Vivanco from the Trastuzumab Trastuzumab Time and motion SpainCórdoba (IMIBIC), Universidad de Córdoba, Hospital Reina have published […]